Bifidobacterium lactis Bi-07 Emerging evidence suggests Bi-07 can help reduce bloating and that overly full, pressure-y feeling GLP-1s sometimes create
By the time the FTC could take action against a company like Medvi, it would have served thousands of additional patients
In a 2-year trial, acute pancreatitis was reported in 8 semaglutide-treated patients (0.27 cases per 100 patient-years) and 10 placebo-treated patients (0.33 cases per 100 patient-years), both on a background of standard of care.1 In trials of patients receiving oral semaglutide, pancreatitis was reported as a serious adverse event in 6 patients (0.1 events per 100 patient-years) receiving semaglutide versus 1 in comparator-treated patients (less than 0.1 events per 100 patient-years)
As employers reduce coverage for obesity medicines, drug makers direct-to-consumer platforms offer a way to mitigate out-of-pocket expenses
We understand the clinical science, but just as importantly, we understand the financial and logistical hurdles patients face